Accolade, which provides a platform that helps employees manage their healthcare benefits, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
The Seattle, WA-based company was founded in 2007 and booked $123 million in sales for the 12 months ended November 30, 2019. It plans to list on the Nasdaq under the symbol ACCD. Goldman Sachs, Morgan Stanley, BofA Securities, Piper Sandler, Credit Suisse and SVB Leerink are the joint bookrunners on the deal. No pricing terms were disclosed.
The article Health benefits platform Accolade files for a $100 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
